Selim Gökçe ATICI - 東京カレッジ
東京カレッジ
Postdoctoral Fellow

Selim Gökçe ATICI

Research Interests criminality, mental health, addiction, immigration, affects&emotions, care
01 Research Description

My previous research focused on the cultural practices of psychiatric medicine in cases of criminalized drug use. I studied how medical interventions, incarceration, and the embodied experiences of addiction-related exhaustion among addiction tojisha in Japan reshape the moral and normative limits of justifiable punishment.

Currently, I am working on Japan’s karihomen-sha population, which includes multi-ethnic asylum seekers, paperless drifters, and immigration law violators detained by the Immigration Bureau but released due to documented illness. Broadly, my research interests lie at the intersection of the state-citizen relationship, mental illness and mental health care, and criminality.

02 Short Biography

2016-2024 Graduate Student and Instructor, Anthropology Department, Stanford University

2014-2016 MA Student, Teaching Assistant, Sociology Department, Bogazici University

03 Publications and Other Research Activities

2023. “Social medicine as a state of exception: rethinking responsibility and public medicine through mutual aid events in Japan.” Somatosphere,  November 30, 2023. https://somatosphere.net/social-medicine-as-a-state-of-exception-rethinking-responsibility-and-public-medicine-through-mutual-aid-events-in-japan/.

2023. “Abstract socialities: digital advertising work and behavioural data modelling in Istanbul.” Subjectivity 30, 70–90 (2023). https://doi.org/10.1057/s41286-023-00148-9. 

2022. 「アディクションの人類学」 (adikushon no jinruigaku, The Anthropology of Addiction).” (peer-reviewed) 『精神医療』 (seishiniryo, Psychiatry), 特集『依存症治療の現在』(Special edition: addiction therapy today), translated by 狩野祐人 (Yuto Kano). (6):2022, 79-86. https://ndlsearch.ndl.go.jp/books/R000000004-I032897870.

2022. “The Spaces Between Fault/Lines: Collaborative Politics of Addiction in Japan.” (peer-reviewed academic article) Contemporary Drug Problems, 49(3), 299-318. https://doi.org/10.1177/00914509221084383.


TOP